|
|
Recombinant Human Activin A Hyperactive Protein, CF (1 MG) |
BT-ACTAH-01M |
1 MG |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Activin A Hyperactive Protein, CF (10 ug) |
BT-ACTAH-010 |
10 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Activin A Hyperactive Protein, CF (100 ug) |
BT-ACTAH-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Activin A Hyperactive Protein, CF (50 ug) |
BT-ACTAH-050 |
50 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Activin A Hyperactive Protein, CF (500 ug) |
BT-ACTAH-500 |
500 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable GMP Protein, CF (1 MG) |
BT-FGFBHS-GMP-01M |
1 MG |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable GMP Protein, CF (25 ug) |
BT-FGFBHS-GMP-025 |
25 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable Protein, Animal-Free (1 MG) |
BT-FGFBHS-AFL-01M |
1 MG |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable Protein, Animal-Free (25 ug) |
BT-FGFBHS-AFL-025 |
25 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable Protein, CF (1 MG) |
BT-FGFBHS-01M |
1 MG |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable Protein, CF (10 ug) |
BT-FGFBHS-010 |
10 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable Protein, CF (100 ug) |
BT-FGFBHS-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable Protein, CF (50 ug) |
BT-FGFBHS-050 |
50 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF basic Heat Stable Protein, CF (500 ug) |
BT-FGFBHS-500 |
500 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF-10 Heat Stable Protein, CF |
BT-FGF10HS-050 |
50 µg |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF-10 Heat Stable Protein, CF |
BT-FGF10HS-500 |
500 µg |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF-10 Heat Stable Protein, CF |
BT-FGF10HS-025 |
25 µg |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF-10 Heat Stable Protein, CF |
BT-FGF10HS-100 |
100 µg |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human FGF-10 Heat Stable Protein, CF |
BT-FGF10HS-01M |
1 mg |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human IL-2 Heat Stable Agonist Protein, CF (1 MG) |
BT-002HS-050 |
1 MG |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human IL-2 Heat Stable Agonist Protein, CF (10 ug) |
BT-002HS-010 |
10 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human IL-2 Heat Stable Agonist Protein, CF (100 ug) |
BT-002HS-500 |
100 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human IL-2 Heat Stable Agonist Protein, CF (50 ug) |
BT-002HS-100 |
50 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human IL-2 Heat Stable Agonist Protein, CF (500 ug) |
BT-002HS-01M |
500 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO1 Agonist Protein, CF (1 MG) |
BT-WRSP1-01M |
1 MG |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO1 Agonist Protein, CF (100 ug) |
BT-WRSP1-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO1 Agonist Protein, CF (50 ug) |
BT-WRSP1-050 |
50 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO1 Agonist Protein, CF (500 ug) |
BT-WRSP1-500 |
500 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO2 Agonist Protein, CF (1 MG) |
BT-WRSP2-01M |
1 MG |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO2 Agonist Protein, CF (100 ug) |
BT-WRSP2-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO2 Agonist Protein, CF (50 ug) |
BT-WRSP2-050 |
50 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO2 Agonist Protein, CF (500 ug) |
BT-WRSP2-500 |
500 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO3 Agonist Protein, CF (1 MG) |
BT-WRSP3-01M |
1 MG |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO3 Agonist Protein, CF (100 ug) |
BT-WRSP3-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO3 Agonist Protein, CF (50 ug) |
BT-WRSP3-050 |
50 ug |
R&D SYSTEMS |
|
|
|
|
|
Recombinant Human Wnt/RSPO3 Agonist Protein, CF (500 ug) |
BT-WRSP3-500 |
500 ug |
R&D SYSTEMS |
|
|
|